{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T04:04:30Z","timestamp":1773201870321,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.medcli.2013.11.026","type":"journal-article","created":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T15:39:59Z","timestamp":1391009999000},"page":"354-359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Beneficios y riesgos de la hormona del crecimiento en adultos con d\u00e9ficit de la misma"],"prefix":"10.1016","volume":"143","author":[{"given":"Juan J.","family":"D\u00edez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Cordido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2013.11.026_bib0005","first-page":"218","article-title":"Hacia un concepto del s\u00edndrome de deficiencia de hormona del crecimiento en adultos","volume":"107","author":"D\u00edez","year":"1996","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2013.11.026_bib0010","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0025-7753(00)71334-0","article-title":"El s\u00edndrome de deficiencia de hormona del crecimiento en adultos: criterios actuales para el diagn\u00f3stico y tratamiento","volume":"114","author":"D\u00edez","year":"2000","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2013.11.026_bib0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1530\/eje.0.1490117","article-title":"Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients","volume":"149","author":"Cordido","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.medcli.2013.11.026_bib0020","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0026-0495(95)90187-6","article-title":"Effect of combined administration of growth hormone (GH)-releasing hormone, GH-releasing peptide-6, and pyridostigmine in normal and obese subjects","volume":"44","author":"Cordido","year":"1995","journal-title":"Metabolism"},{"key":"10.1016\/j.medcli.2013.11.026_bib0025","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: An Endocrine Society clinical practice guideline","volume":"96","author":"Molitch","year":"2011","journal-title":"J Clin Endcrinol Metab"},{"key":"10.1016\/j.medcli.2013.11.026_bib0030","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/EJE-12-1088","article-title":"Long-term effects of recombinant human GH replacement in adults with GH deficiency: A systematic review","volume":"169","author":"Appelman-Dijkstra","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.medcli.2013.11.026_bib0035","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM198912283212605","article-title":"The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency","volume":"321","author":"Salomon","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2013.11.026_bib0040","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1530\/EJE-12-1083","article-title":"Fifteen years of GH replacement improves body composition and cardiovascular risk factors","volume":"168","author":"Elbornsson","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.medcli.2013.11.026_bib0045","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1210\/jc.2012-2006","article-title":"Discontinuing long-term GH replacement therapy--A randomized, placebo-controlled crossover trial in adult GH deficiency","volume":"97","author":"Filipsson Nystr\u00f6m","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2013.11.026_bib0050","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1210\/jc.2008-1538","article-title":"Ten years of growth hormone (GH) replacement normalizes muscle strength in GH-deficient adults","volume":"94","author":"Gotherstrom","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2013.11.026_bib0055","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.medcli.2010.07.030","article-title":"Terapia sustitutiva a largo plazo del d\u00e9ficit de hormona del crecimiento en la edad adulta","volume":"136","author":"Cabo","year":"2011","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2013.11.026_bib0060","first-page":"970","article-title":"Withdrawal of long-term physiological growth hormone (GH) administration: Differential effects on bone density and body composition in men with adult-onset GH deficiency","volume":"85","author":"Biller","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2013.11.026_bib0065","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1210\/jc.2003-030204","article-title":"Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: A two-year, multicenter, multiple-dose, placebo-controlled study","volume":"88","author":"Underwood","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2013.11.026_bib0070","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1210\/jc.2003-030134","article-title":"Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H)","volume":"89","author":"Rosilio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2013.11.026_bib0075","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1210\/jc.2012-2477","article-title":"GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiency","volume":"97","author":"Giavoli","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2013.11.026_bib0080","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1210\/jcem.84.8.5916","article-title":"The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients","volume":"84","author":"Gibney","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2013.11.026_bib0085","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1210\/jc.2003-030346","article-title":"Growth hormone (GH) replacement therapy in adult-onset gh deficiency: Effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial","volume":"89","author":"Hoffman","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2013.11.026_bib0090","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2003-030840","article-title":"Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: A metaanalysis of blinded, randomized, placebo-controlled trials","volume":"89","author":"Maison","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2013.11.026_bib0095","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1210\/jc.2012-2794","article-title":"Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: A randomized controlled trial","volume":"97","author":"Makimura","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2013.11.026_bib0100","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1530\/EJE-12-1037","article-title":"Impact of GH replacement therapy on sleep in adult patients with GH deficiency of pituitary origin","volume":"168","author":"Morselli","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.medcli.2013.11.026_bib0105","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","article-title":"Premature mortality due to cardiovascular disease in hypopituitarism","volume":"336","author":"Ros\u00e9n","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2013.11.026_bib0110","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1210\/jc.2003-031601","article-title":"Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy","volume":"89","author":"Svensson","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2013.11.026_bib0115","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2013.11.026_bib0120","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1210\/jc.2012-2940","article-title":"Metabolic profile in growth hormone-deficient (GHD) adults after long-term recombinant human growth hormone (rhGH) therapy","volume":"98","author":"Claessen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2013.11.026_bib0125","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1210\/jc.2003-030685","article-title":"Low bone mass is an infrequent feature of the adult growth hormone deficiency syndrome in middle-age adults and the elderly","volume":"89","author":"Murray","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2013.11.026_bib0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ghir.2011.01.001","article-title":"Favorable long-term effects of growth hormone replacement therapy on quality of life, bone metabolism, body composition and lipid levels in patients with adult-onset growth hormone deficiency","volume":"21","author":"J\u00f8rgensen","year":"2011","journal-title":"Growth Horm IGF Res"},{"issue":"Suppl 1","key":"10.1016\/j.medcli.2013.11.026_bib0135","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1530\/EJE-09-0266","article-title":"Assessment of quality of life in adult patients with GH deficiency. KIMS contribution to clinical practice and pharmacoeconomic evaluations","volume":"161","author":"Koltowska-H\u00e4ggstr\u00f6m","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.medcli.2013.11.026_bib0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1530\/EJE-08-0738","article-title":"Health-related quality of life and IGF-1 in GH-deficient adult patients on GH replacement therapy: Analysis of the German KIMS data and the Study of Health in Pomerania","volume":"160","author":"Mook","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.medcli.2013.11.026_bib0145","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1530\/EJE-07-0016","article-title":"Heterogeneity in responsiveness of perceived quality of life to body composition changes between adult- and childhood-onset Japanese hypopituitary adults with GH deficiency during GH replacement","volume":"156","author":"Urushihara","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.medcli.2013.11.026_bib0150","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1054\/ghir.2000.0172","article-title":"Changes in lipoprotein (a) levels measured by six kit methods during growth hormone treatment of growth hormone deficient adults","volume":"10","author":"Wiersinga","year":"2000","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.medcli.2013.11.026_bib0155","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1210\/jc.2007-1636","article-title":"Congenital growth hormone (GH) deficiency and atherosclerosis: Effects of GH replacement in GH-naive adults","volume":"92","author":"Oliveira","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"10.1016\/j.medcli.2013.11.026_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.15.S2.1","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients-2009 update","volume":"15","author":"Cook","year":"2009","journal-title":"Endocr Pract"},{"key":"10.1016\/j.medcli.2013.11.026_bib0165","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.medcli.2010.12.020","article-title":"Aplicaciones de la hormona del crecimiento en humanos","volume":"137","year":"2011","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2013.11.026_bib0170","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2265.2000.01108.x","article-title":"Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: A two year study","volume":"53","author":"Florakis","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.medcli.2013.11.026_bib0175","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1210\/jc.2011-0448","article-title":"Prevalence and incidence of diabetes mellitus in adult patients on growth hormone replacement of growth hormone deficiency: A surveillance database analysis","volume":"96","author":"Attanasio","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2013.11.026_bib0180","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2337\/dc11-0449","article-title":"Incidence of diabetes mellitus and evolution of glucose parameters in growth hormone-deficient subjects during growth hormone replacement therapy: A long-term observational study","volume":"35","author":"Luger","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.medcli.2013.11.026_bib0185","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0140-6736(02)09519-3","article-title":"Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: A cohort study","volume":"360","author":"Swerdlow","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2013.11.026_bib0190","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1210\/jc.2009-0178","article-title":"Long-term safety of recombinant human growth hormone in children","volume":"95","author":"Bell","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2013.11.026_bib0195","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jpeds.2010.02.028","article-title":"Growth hormone treatment in children is not associated with an increase in the incidence of cancer: Experience from KIGS (Pfizer International Growth Database)","volume":"157","author":"Wilton","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.medcli.2013.11.026_bib0200","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1210\/jcem.87.7.8606","article-title":"Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: A report from the Childhood Cancer Survivor Study","volume":"87","author":"Sklar","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2013.11.026_bib0205","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1210\/jc.2006-0656","article-title":"Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor","volume":"91","author":"Ergun-Longmire","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1016\/j.medcli.2013.11.026_bib0210","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1530\/EJE-09-0287","article-title":"Safety aspects of GH replacement","volume":"161","author":"Svensson","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.medcli.2013.11.026_bib0215","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1210\/jc.2011-1995","article-title":"Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: Preliminary report of the French SAGhE study","volume":"97","author":"Carel","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2013.11.026_bib0220","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1530\/EJE-11-0286","article-title":"Assessment of primary cancers in GH-treated adult hypopituitary patients: An analysis from the Hypopituitary Control and Complications Study","volume":"165","author":"Child","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.medcli.2013.11.026_bib0225","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1210\/jc.2011-1215","article-title":"Does growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency? Data from the Dutch National Registry of Growth Hormone Treatment in adults","volume":"96","author":"Van Bunderen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2013.11.026_bib0230","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S1096-6374(08)70010-8","article-title":"Cause-specific mortality in patients from the KIMS database and associations with IGF-I standard deviation scores (SDS)","volume":"18","author":"Wilton","year":"2008","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.medcli.2013.11.026_bib0235","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1530\/EJE-11-1028","article-title":"Overall and cause-specific mortality in GH-deficient adults on GH replacement","volume":"166","author":"Gaillard","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.medcli.2013.11.026_bib0240","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.medcli.2012.07.024","article-title":"Optimizaci\u00f3n del tratamiento m\u00e9dico de la acromegalia","volume":"140","author":"D\u00edez","year":"2013","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2013.11.026_bib0245","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1210\/jc.2010-2819","article-title":"Effects of once-weekly sustained-release growth hormone: A double-blind, placebo-controlled study in adult growth hormone deficiency","volume":"96","author":"Biller","year":"2011","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775313008579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775313008579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T01:51:07Z","timestamp":1538877067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775313008579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0025775313008579"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2013.11.026","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beneficios y riesgos de la hormona del crecimiento en adultos con d\u00e9ficit de la misma","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2013.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}